The donated chemical probe programme: advancing biomedical research through open science

Chemical probes enable selective modulation of protein function in live cells, making them valuable tools for studying the roles of proteins in normal and disease physiology. Although initiatives such as the chemical probe development programme at the Structural Genomics Consortium have expanded access to chemial probes for selected target classes, the general availability across the druggable proteome remains limited, particularly for compounds developed within the pharmaceutical industry. The donated chemical probe (DCP) programme addresses this gap through an open-science model that combines unrestricted access to donated probes with comprehensive characterisation data and independent expert review. Since its launch in 2017, the programme has become an important resource for basic as well as translational research. More than 20 organisations have contributed to the initiative, resulting in a collection of about 140 chemical probes together with matched control compounds and previously inaccessible characterisation data that had often remained confined to patents or internal reports. The present review summarises recent developments of the DCP programme and highlights representative examples including case studies such as the BUB1 chemical probe BAY 1816032.

Authors

Institutions

Publication Details

Journal
Essays in Biochemistry
Published
2026-11-19
DOI
https://doi.org/10.1042/ebc20260005
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The donated chemical probe programme: advancing biomedical research through open science

Claudia Tredup, Sandra Haeberle
Essays in Biochemistry
Computational Drug Discovery Methods
article

The donated chemical probe programme: advancing biomedical research through open science

Claudia Tredup, Sandra Haeberle
article en

Abstract

Chemical probes enable selective modulation of protein function in live cells, making them valuable tools for studying the roles of proteins in normal and disease physiology. Although initiatives such as the chemical probe development programme at the Structural Genomics Consortium have expanded access to chemial probes for selected target classes, the general availability across the druggable proteome remains limited, particularly for compounds developed within the pharmaceutical industry. The donated chemical probe (DCP) programme addresses this gap through an open-science model that combines unrestricted access to donated probes with comprehensive characterisation data and independent expert review. Since its launch in 2017, the programme has become an important resource for basic as well as translational research. More than 20 organisations have contributed to the initiative, resulting in a collection of about 140 chemical probes together with matched control compounds and previously inaccessible characterisation data that had often remained confined to patents or internal reports. The present review summarises recent developments of the DCP programme and highlights representative examples including case studies such as the BUB1 chemical probe BAY 1816032.

Essays in Biochemistry
Goethe University Frankfurt (DE), Structural Genomics Consortium (CA)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon